Retour aux projets

16018.2 PFLS-LS

Targeting of the IL-23 Receptor to eliminate auto-reactive lymphocytes in chronic inflammatory diseases

Résumé

Targeting of the IL-23 Receptor to eliminate auto-reactive lymphocytes in chronic inflammatory diseases

Textes supplémentaires

Abstract

A novel mechanism of action for the sustainable therapy of human chronic inflammatory diseases, acting|through targeted lysis of disease-driving cell, shall be investigated here. A lead molecule active in human|and non-human primates has been identified and will be developed to enable clinical testing. To support|the preclinical development a bispecific surrogate antibody fragment active in mice will be engineered and|tested in relevant mouse models for chronic inflammatory diseases to study efficacy as well as certain|safety relevant parameters.

Participants

David Urech

Wirtschaftspartner

d.urech@numab.com

Numab AG David Urech Einsiedlerstrasse 34 8820 Wädenswil ZH CH

Burkhard Becher

Kontaktperson

becher@immunology.uzh.ch

Universität Zürich Burkhard Becher Winterthurerstrasse 190 8057 Zürich ZH CH

Détails du projet

Office de recherche
INNOSUISSE
Statut du projet
Abgeschlossen
Type de projet
Forschungsprojekt
Date de début
2014-02-28
Date de fin
2016-12-31
Coûts totaux approuvés
CHF 690580.00
Section
20 Förderbereich Life Sciences
Domaine politique NABS
Industrielle Produktivität und Technologie

Disciplines de recherche

  • T490 Biotechnology 100.0%